摘要
沙库巴曲缬沙坦作为首个血管紧张素受体脑啡肽酶抑制剂,在高血压及心力衰竭中具有确切的治疗效果,同时在心律失常及肺动脉高压等心血管疾病中表现出潜在的治疗效果,现就该药物在心血管疾病中的临床应用与展望进行综述。
As the first angiotensin receptor-neprilysin inhibitor,sacubitril valsartan has a good therapeutic effect on hypertension and heart failure,and has potential effect on other cardiovascular diseases such as arrhythmia and pulmonary hypertension.Therefore,this paper reviews the clinical application and prospect of this drug in cardiovascular diseases.
作者
程家元
殷跃辉
CHENG Jiayuan;YIN Yuehui(Chongqing Medical University Graduate School,Chongqing 400010,China;Department of Cardiology,The Second Affiliated Hospital of Chongqing Medical University,Chongqing 400010,China)
出处
《心血管病学进展》
CAS
2020年第9期914-916,929,共4页
Advances in Cardiovascular Diseases
